drugset / Trial / NCT06760078
Tranexamic Acid with Intensive Blood Pressure Management in Ultra-Early Intracerebral Hemorrhage
Phase 4
Not yet recruiting
532 enrolled
Xuanwu Hospital, Beijing
Beijing Aerospace Center Hospital · collabBeijing Municipal Health Commission · collabCapital Medical University · collabHuizhou Third People's Hospital, Guangzhou Medical University · collabHunan Provincial People's Hospital · collabJiaozuo Tumor Hospital · collabLinyi People's Hospital · collabNanyang Nanshi Hospital, Henan University · collabPeking University Care Luzhong Hospital · collabSuzhou First People's Hospital · collabThe First Affiliated Hospital of Hebei North University · collabThe First People's Hospital of Qujing, Yunnan Province · collabThe People's Hospital of Liaoning Province · collabWuzhou Red Cross Hospital · collabXing'anmeng People's Hospital · collabYantai Penglai Traditional Chinese Medicine Hospital · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a prospective, multicenter, randomized, quadruple-blind, placebo-controlled study. This study aims to estimate the safety and efficacy of intravenous tranexamic acid (TXA) combined with intensive blood pressure lowering in ultra-early spontaneous intracerebral hemorrhage (ICH).
Timeline
- Start
- 2024-12-31
- Primary completion
- 2025-12-31
- Completion
- 2026-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tranexamic Acid | Small molecule | 1 g | Intravenous |